Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.7K
The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

84
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Neuro-oncology advances·2026
Same author

Invasive Pneumococcal Disease among Childbearing-Age Women, United States, 2007-2023.

Emerging infectious diseases·2026
Same author

Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Group A Streptococcus Meningitis, United States, 1997-2022.

Emerging infectious diseases·2026
Same author

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Nature medicine·2026
Same author

Acute Respiratory Infections Due to Antibiotic-nonsusceptible <i>Streptococcus pneumoniae</i> in US Adults.

Open forum infectious diseases·2026
Same journal

Ifebemtinib plus garsorasib as first-line treatment for KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial.

The Lancet. Respiratory medicine·2026
Same journal

FAK co-inhibition in KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer.

The Lancet. Respiratory medicine·2026
Same journal

Asthma diagnosis in adults and children: challenges, future directions, and a call to action.

The Lancet. Respiratory medicine·2026
Same journal

The PERC-Peds rule: a promising step towards structured pulmonary embolism risk assessment in children.

The Lancet. Respiratory medicine·2026
Same journal

Intensive care in global conflicts: brace for impact.

The Lancet. Respiratory medicine·2026
Same journal

PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study.

The Lancet. Respiratory medicine·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Childhood pneumonia in developing countries.

Rasa Izadnegahdar1, Adam L Cohen2, Keith P Klugman3

  • 1Center for Global Health and Development, Boston University, Boston, MA, USA.

The Lancet. Respiratory Medicine
|January 28, 2014
PubMed
Summary
This summary is machine-generated.

Pneumonia remains a major threat to young children globally, especially in developing nations. Improved diagnostic methods and broader treatment strategies are crucial to reduce child mortality from this infectious lung disease.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.3K
A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

8.8K

Related Experiment Videos

Last Updated: May 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.3K
A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

8.8K

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pneumonia is a leading infectious cause of death in children under five, particularly in resource-limited settings.
  • Accurate diagnosis of pneumonia is challenging, even with supplementary tests, leading to potential misdiagnosis and inadequate treatment.
  • Despite advances, significant disparities in care access persist between developed and developing countries.

Purpose of the Study:

  • To highlight the diagnostic challenges in pediatric pneumonia.
  • To emphasize the need for improved treatment interventions beyond vaccines and antibiotics.
  • To underscore the importance of addressing the burden of pneumonia for child survival.

Main Methods:

  • The abstract does not detail specific methods but discusses clinical, laboratory, and radiological diagnostic approaches.
  • It reviews existing prevention programs and treatment guidelines.
  • It highlights the impact of limited access to care in developing countries.

Main Results:

  • Pneumonia caused an estimated 1.2 million deaths in children under five in 2011.
  • Diagnostic accuracy for pneumonia remains suboptimal, with limited improvement from additional tests.
  • Children in developing countries face higher risks due to scarce resources and limited access to advanced interventions.

Conclusions:

  • Further research is needed to overcome challenges in etiological diagnosis of pneumonia.
  • Widespread implementation of treatment interventions beyond vaccines and antibiotics is essential.
  • Mitigating the burden of pneumonia requires improved diagnostics and equitable access to care to enhance child survival rates.